Page last updated: 2024-11-04

rofecoxib and Aortic Aneurysm, Abdominal

rofecoxib has been researched along with Aortic Aneurysm, Abdominal in 2 studies

Aortic Aneurysm, Abdominal: An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.

Research Excerpts

ExcerptRelevanceReference
"The rat model of abdominal aortic aneurysm (AAA) is associated with inflammation, destruction of extracellular matrix, and production of both inducible nitric oxide synthase (iNOS) and matrix metalloproteinase-9 (MMP-9)."1.33Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. ( Armstrong, PJ; Carey, DJ; Elmore, JR; Franklin, DP, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SoRelle, R1
Armstrong, PJ1
Franklin, DP1
Carey, DJ1
Elmore, JR1

Other Studies

2 other studies available for rofecoxib and Aortic Aneurysm, Abdominal

ArticleYear
Rofecoxib use increases acute myocardial infarction risk.
    Circulation, 2004, May-04, Volume: 109, Issue:17

    Topics: Aortic Aneurysm, Abdominal; Benzazepines; Cardiology; Cholesterol; Female; Heart Failure; Humans; La

2004
Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors.
    Annals of vascular surgery, 2005, Volume: 19, Issue:2

    Topics: Amidines; Animals; Aortic Aneurysm, Abdominal; Benzylamines; Blotting, Western; Cyclooxygenase Inhib

2005